BXP, Inc. Q2 FY26 Earnings Analysis

Published 30 May 2026 | Office REITs | Market Cap: ₹9.7K Cr

Price

60.63

Market Cap

₹9.7K Cr

P/E Ratio

30.5

Revenue Rank

Rank 4

Margin Rank

Rank 2

Earnings Summary

- Strong leasing performance continues to exceed expectations, supporting stronger occupancy recovery and growth outlook (Page 6). - BXP raised its 2026 FFO per share guidance by $0.01, with a new range of $6.90 to $7.04 per share.

📊 Revenue & Sales Performance

Rank 4

- Strong leasing performance continues to exceed expectations, supporting stronger occupancy recovery and growth outlook (Page 6). - Increased same-property NOI growth forecast for 2026, raised by 15 basis points to between 1.4% and 2.4% (Page 6). - Leasing activity robust with 1.6 million square feet of signed leases yet to take occupancy and a pipeline of 3 million square feet under negotiation or discussion, higher than last quarter (Page 6). - AI and tech-driven demand accelerating, especially in markets like San Francisco and Midtown South New York, contributing to positive absorption over several quarters (Pages 5, 8, and 12). - Occupancy outlook increased for 2026 by 25 basis points to 88.25%, expecting further increases into 2027 and beyond, with occupancy targeted at 89% end of 2026 and 91%+ in 2027 (Pages 14). - Continued development activity, including early delivery of key projects like 290 Binney Street, contributing to growth (Page 6).

📈 Profitability & Margins

Rank 2

- BXP raised its 2026 FFO per share guidance by $0.01, with a new range of $6.90 to $7.04 per share. - Increased same-property NOI growth expectation for 2026 to between 1.4% and 2.4%, excluding termination income. - Strong leasing activity and occupancy improvements support higher portfolio performance and value. - Lease termination income assumptions increased, positively impacting 2026 earnings. - Development projects (e.g., 290 Benny Street) contributing to incremental income, albeit with higher interest expenses. - Expect continuation of occupancy gains with a target of 4 percentage points improvement over 2026-2027. - Asset sales and recapitalization expected to be accretive, freeing capital for further investments and deleveraging. - Overall, BXP remains confident in external growth, FFO per share growth, and portfolio value increases in coming years.

🏗️ Capital Expenditure Plans

Yes

- BXP is allocating capital to new developments generating 8%+ yields, considered accretive and more attractive than share repurchases or acquisitions. - Current development pipeline includes 6 projects (office, life science, residential) totaling 3.4 million sq ft and $3.6 billion investment. - Largest ongoing development: 343 Madison Ave in NYC, with 56% leased/pre-leased, expected stabilized unleveraged cash return of 7.5%-8% upon delivery in 2029. - Over 83% of construction costs for 343 Madison have been procured with savings realized; recapitalization targeted in 2026 involving multiple partners and construction financing. - Leasing CapEx is elevated due to significant lease commencements; full-year leasing costs expected to exceed $400 million, driven by occupancy growth. - Focus on turnkey/prebuilt suites to expedite tenancy for tech and AI companies. - Development program may feature fewer but higher-cost projects; residential projects expected to have lower capital intensity.

💰 Fundraising & Capital Structure

Yes

- BXP is close to completing a construction loan for 343 Madison Avenue and plans to finalize a recapitalization in 2026, potentially involving multiple equity partners with 30% to 50% leveraged interest. - They have an agreed letter of intent with a consortium of banks for construction financing at attractive terms. - Discussions are ongoing with several potential equity partners for 343 Madison Avenue. - The company expects to raise capital through this recapitalization to deleverage and free up capital for additional investments. - Future developments will likely involve financial partners owning the majority of the equity, similar to past models like 17 Heartwell and Skymark. - No share repurchases planned currently as the focus remains on debt reduction and development yield opportunities.

📋 Order Book & Pipeline

No information

- As of March 31, the current pipeline of leases in negotiation consists of 1.7 million square feet. - This covers 500,000 square feet of existing vacancies and 500,000 square feet of 2026 and 2027 expirations. - Started Q2 with 1.44 million square feet of executed leases on vacant space expected to commence in 2026. - Total discussions pipeline, in addition to leases in negotiation, includes another 1.4 million square feet. - Total leases executed post-March 31 are 300,000 square feet, bringing the total for 2026 to 1.5 million square feet. - 20 requirements are over 100,000 square feet, totaling about 3.3 million square feet. - Expect a minimum of 4 million square feet of leasing in 2026, consistent with 2026 guidance.

Key Metrics

Revenue

Rank 4

Margin

Rank 2

Capex

Yes

Fundraise

Yes

Order Book

No information

Frequently Asked Questions

What were BXP, Inc. Q2 FY26 results?

- Strong leasing performance continues to exceed expectations, supporting stronger occupancy recovery and growth outlook (Page 6). - BXP raised its 2026 FFO per share guidance by $0.01, with a new range of $6.90 to $7.04 per share.

What is BXP, Inc. share price analysis?

BXP, Inc. currently shows a neutral. The stock trades at a P/E of 30.5 with a market cap of $9,669. Investors should review the full earnings analysis for detailed insights.

Is BXP, Inc. planning capital expenditure?

- BXP is allocating capital to new developments generating 8%+ yields, considered accretive and more attractive than share repurchases or acquisitions.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.